Healthcare -
Biotechnology - NASDAQ - US
$ 12.05
-14.9 %
$ 178 M
Market Cap
-0.54
P/E
LYEL - OPERATING INCOME
Operating Income LYEL - Lyell Immunopharma, Inc.
-359 M
LAST VALUE
-39.97%
2 YEAR CAGR
-28.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR